China Generics 麻豆原创 Summary, Competitive Analysis and Forecast, 2017-2026

You are here: 麻豆原创 Catalog Pharma & Healthcare Generic Drugs

China Generics 麻豆原创 Summary, Competitive Analysis and Forecast, 2017-2026

麻豆原创 Research Report Summary

China Generics 麻豆原创 Summary, Competitive Analysis and Forecast, 2017-2026 report is published on July 6, 2022 and has 46 pages in it. This market research report provides information about Generic Drugs, Pharma & Healthcare industry. It covers China market data and forecasts. It is priced starting at USD 350.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

China Generics 麻豆原创 Summary, Competitive Analysis and Forecast, 2017-2026

Printer version

Send by email

Publication ID:听

MLI09220039

Publication Date:听

July 6, 2022

笔补驳别蝉:听

46

笔耻产濒颈蝉丑别谤:听

麻豆原创Line

颁辞耻苍迟谤颈别蝉:听

China

USD 350.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

China Generics 麻豆原创 Summary, Competitive Analysis and Forecast, 2017-2026

Summary

Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Chinese generics market had total revenues of $85.3bn in 2021, representing a compound annual growth rate (CAGR) of 7.3% between 2016 and 2021.
- 麻豆原创 consumption volume increased with a CAGR of 1.5% between 2016 and 2021, to reach a total of 97.0 % in 2021.
- Over the past five years, the Chinese market recorded growth of 7.8%. Growth in the market has been driven by demographic trends, primarily the general aging of the population.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in China
- Leading company profiles reveal details of key generics market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China generics market with five year forecasts

Reasons to Buy

- What was the size of the China generics market by value in 2021?
- What will be the size of the China generics market in 2026?
- What factors are affecting the strength of competition in the China generics market?
- How has the market performed over the last five years?
- What are the main segments that make up China's generics market?

Table of Contents

Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. 麻豆原创 volume
1.4. 麻豆原创 volume forecast
1.5. Geography segmentation
1.6. 麻豆原创 rivalry
1.7. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
3.2. 麻豆原创 volume
4 麻豆原创 Segmentation
4.1. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
5.2. 麻豆原创 volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How did the COVID-19 pandemic impact leading players?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. China Grand Pharmaceutical and Healthcare Holdings Limited
8.4. Pfizer Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line

List of Tables
List of Tables
Table 1: China generics market value: $ billion, 2016-21
Table 2: China generics market volume: %, 2016-21
Table 3: China generics market geography segmentation: $ billion, 2021
Table 4: China generics market value forecast: $ billion, 2021-26
Table 5: China generics market volume forecast: %, 2021-26
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Viatris Inc.: Key Employees Continued
Table 13: China Grand Pharmaceutical and Healthcare Holdings Limited: key facts
Table 14: China Grand Pharmaceutical and Healthcare Holdings Limited: Annual Financial Ratios
Table 15: China Grand Pharmaceutical and Healthcare Holdings Limited: Key Employees
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: Annual Financial Ratios
Table 18: Pfizer Inc.: Key Employees
Table 19: Pfizer Inc.: Key Employees Continued
Table 20: China size of population (million), 2017-21
Table 21: China gdp (constant 2005 prices, $ billion), 2017-21
Table 22: China gdp (current prices, $ billion), 2017-21
Table 23: China inflation, 2017-21
Table 24: China consumer price index (absolute), 2017-21
Table 25: China exchange rate, 2017-21

List of Figures
List of Figures
Figure 1: China generics market value: $ billion, 2016-21
Figure 2: China generics market volume: %, 2016-21
Figure 3: China generics market geography segmentation: % share, by value, 2021
Figure 4: China generics market value forecast: $ billion, 2021-26
Figure 5: China generics market volume forecast: %, 2021-26
Figure 6: Forces driving competition in the generics market in China, 2021
Figure 7: Drivers of buyer power in the generics market in China, 2021
Figure 8: Drivers of supplier power in the generics market in China, 2021
Figure 9: Factors influencing the likelihood of new entrants in the generics market in China, 2021
Figure 10: Factors influencing the threat of substitutes in the generics market in China, 2021
Figure 11: Drivers of degree of rivalry in the generics market in China, 2021

Companies Covered

Teva Pharmaceutical Industries Limited
Viatris Inc.
China Grand Pharmaceutical and Healthcare Holdings Limited
Pfizer Inc.

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Generic Drugs

Pharma & Healthcare

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
North America (NAFTA) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 North America (NAFTA) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Summary The NAFTA Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The generics industry within the NAFTA countries had a total market value of $82,183.1 million in 2022.The Canada was the fastest growing country, with a CAGR of 4.7% over the 2018-22 period. - Within the generics industry, the US is the leading country among the NAFTA bloc, with market revenues of $69,916.7 million in 2022. This was followed by Canada and Mexico, with a value of $6...Read more	USD 795.00
BRIC Countries (Brazil, Russia, India, China) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 BRIC Countries (Brazil, Russia, India, China) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Summary The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the generics industry and had a total market value of $144,339.7 million in 2022. China was the fastest growing country with a CAGR of 14.1% over the 2018-22 period. - Within the generics industry, China is the leading country among the BRIC nations with market revenues of $111,666.9 million in 2022. This was followed by India, Russia and Brazil with a value of $17,617.5, $11,917.6, and $3,137...Read more	USD 995.00
Top 5 Emerging Countries Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Top 5 Emerging Countries Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Summary The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - These countries contributed $139,492.2 million to the global generics industry in 2022, with a compound annual growth rate (CAGR) of 12.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $210,704.1 million in 2027, with a CAGR of 8.6% over the 2022-27 period. - Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $111,666.9 million in 2022. This was followed by India and Mexico with a value of $17,617.5 and $...Read more	USD 995.00
Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 Summary Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. - 麻豆原创 volume is quantified here as the percentage of the total...Read more	USD 1,495.00
Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 (Global Almanac) Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 (Global Almanac) Summary Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. - 麻豆原创 volume is quantified here as the...Read more	USD 2,995.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创